Omega Protein Corporation (NYSE:OME) was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Monday.

OME has been the subject of a number of other research reports. Pivotal Research lowered their price target on Omega Protein Corporation from $18.00 to $15.00 and set a “hold” rating for the company in a report on Friday, July 7th. BidaskClub cut Omega Protein Corporation from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 19th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $21.50.

Omega Protein Corporation (OME) opened at 16.85 on Monday. The company has a market capitalization of $378.52 million, a P/E ratio of 11.79 and a beta of 0.28. Omega Protein Corporation has a 1-year low of $14.50 and a 1-year high of $26.99. The company has a 50-day moving average of $16.16 and a 200-day moving average of $17.61.

Omega Protein Corporation (NYSE:OME) last released its earnings results on Wednesday, August 2nd. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.08. Omega Protein Corporation had a return on equity of 10.46% and a net margin of 8.95%. The business had revenue of $93.90 million for the quarter, compared to analyst estimates of $87.44 million. During the same quarter last year, the firm posted $0.62 earnings per share. The business’s revenue was down 16.7% compared to the same quarter last year. Equities analysts expect that Omega Protein Corporation will post $1.07 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/omega-protein-corporation-ome-stock-rating-upgraded-by-valuengine/1607114.html.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Victory Capital Management Inc. raised its holdings in Omega Protein Corporation by 229.0% in the first quarter. Victory Capital Management Inc. now owns 7,850 shares of the company’s stock worth $157,000 after purchasing an additional 5,464 shares in the last quarter. Eqis Capital Management Inc. purchased a new stake in Omega Protein Corporation during the second quarter valued at approximately $183,000. AHL Partners LLP purchased a new stake in Omega Protein Corporation during the second quarter valued at approximately $189,000. Voya Investment Management LLC lifted its position in Omega Protein Corporation by 16.2% during the second quarter. Voya Investment Management LLC now owns 11,668 shares of the company’s stock valued at $209,000 after acquiring an additional 1,626 shares during the last quarter. Finally, UBS Group AG lifted its position in Omega Protein Corporation by 191.6% during the first quarter. UBS Group AG now owns 12,575 shares of the company’s stock valued at $252,000 after acquiring an additional 8,262 shares during the last quarter. Institutional investors own 86.83% of the company’s stock.

Omega Protein Corporation Company Profile

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).

Receive News & Ratings for Omega Protein Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.